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Background. Although many genes with important function
in kidney morphogenesis have been described, it is clear that
many more remain to be discovered. Microarrays allow a more
global analysis of the genetic basis of kidney organogenesis.
Methods. In this study, Affymetrix U74Av2 microarrays,
with over 12,000 genes represented, were used in conjunction
with robust target microamplification techniques to define the
gene expression profiles of the developing mouse kidney.
Results. Microdissected murine ureteric bud and metaneph-
ric mesenchyme as well as total kidneys at embryonic day
E11.5, E12.5, E13.5, E16.5, and adult were examined. This
work identified, for example, 3847 genes expressed in the E12.5
kidney. Stringent comparison of the E12.5 versus adult recog-
nized 428 genes with significantly elevated expression in the
embryonic kidney. These genes fell into several functional cate-
gories, including transcription factor, growth factor, signal
transduction, cell cycle, and others. In contrast, surprisingly
few differences were found in the gene expression profiles of
the ureteric bud and metanephric mesenchyme, with many
of the differences clearly associated with the more epithelial
character of the bud. In situ hybridizations were used to confirm
and extend microarray-predicted expression patterns in the
developing kidney. For three genes, Cdrap, Tgfbi, and Col15a1,
we observed strikingly similar expression in the developing
kidneys and lungs, which both undergo branching morphogen-
esis.
Conclusion. The results provide a gene discovery function,
identifying large numbers of genes not previously associated
with kidney development. This study extends developing kid-
ney microarray analysis to the powerful genetic system of the
mouse and establishes a baseline for future examination of
the many available mutants. This work creates a catalogue of
the gene expression states of the developing mouse kidney and
its microdissected subcomponents.
The kidney provides a powerful model system for
study of the principles of organogenesis. The develop-
ing kidney employs many developmental mechanisms,
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including budding, reciprocal inductive tissue interac-
tions, stem cell growth and differentiation, cell polariza-
tion, mesenchyme to epithelia transformation, branching
morphogenesis, angiogenesis, apoptosis, fusion (neph-
rons to collecting ducts), proximal-distal segmentation
(along the length of the nephron), and the differentiation
of several interesting cell types. Furthermore, nephro-
genesis proceeds readily in culture [1], providing an im-
portant experimental advantage.
Significant advances have been made in understand-
ing the genetic basis of kidney organogenesis. The un-
induced metanephric mesenchyme produces glial-derived
neurotrophic factor (GDNF), which interacts with the
ret receptor on the ureteric bud to promote outgrowth.
Mice with mutation of either the GDNF or ret, or its
coreceptor the GFRa1 gene, have severe failure of kid-
ney development [2, 3]. There is also strong evidence
implicating pleiotrophin as a mesenchyme-synthesized
inducer of the ureteric bud and branching morphogene-
sis [4]. The initial signaling from the bud to the meta-
nephric mesenchyme is less well understood, but Wnt6,
synthesized by the bud and able to induce tubulogenesis
in vitro, is a candidate [5].
Kidney organ culture and cell line studies have impli-
cated a number of genes in kidney development, includ-
ing midkine [6], phosphatidylinositol 3 kinase (PI3K) [7],
transforming growth factor-b1 (TGF-1) [8], galectin-3
[9], bone morphogenetic protein-4 (BMP-4) [10], vascu-
lar endothelial growth factor (VEGF) [11], hepatocyte
growth factor (HGF) [12], and others.
Gene-targeting studies have shown that Lim1 [13],
Hoxa 11/Hoxd 11 [14–16], Eya1 [17], WT-1 [18], Sall1
[19], a3 b1 integrin [20], a8 b1 integrin [21], Emx-2 [22],
FOXd1 (BF-2) [23], RARa, and RARb [24] are all essen-
tial for kidney development. BMP-7 is essential for con-
tinued kidney growth [25, 26], and Wnt4, synthesized in
the mesenchyme, is required for development past the
aggregate stage of nephrogenesis [27]. Cadherin-6 pro-
motes mesenchyme to epithelia conversion and nephron
formation [28]. N-Myc promotes cell proliferation [29].
LIF appears an important signal from the later ureteric
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bud to the differentiating nephrons [30]. Despite this
impressive progress, it is clear that we have only begun
to understand the genetic basis of kidney formation.
Microarrays offer the opportunity to determine global
definitions of the gene expression states of developing
organs. As microarrays approach comprehensive cover-
age of the genome, it is becoming possible to assay ex-
pression levels of every gene. As target amplification
procedures become more powerful, it is becoming possi-
ble to perform microarray analysis with ever-decreasing
amounts of starting RNA. The ultimate goal is to define
the complete gene expression patterns of individual cell
types as they progress through kidney organogenesis.
Microarrays have been used to generate gene expres-
sion profiles of cell lines representing specific stages of
kidney development [31]. The mK3 and mK4 cells cor-
respond to early metanephric mesenchyme and later
metanephric mesenchyme, undergoing epithelial trans-
formation. Microarrays identified thousands of genes ex-
pressed in these two cell types and thereby implicated
them in early kidney development. Comparison of the
mK3 and mK4 gene expression profiles found a large
number of genes differently expressed, likely reflecting
changes in gene expression during epithelial transforma-
tion [31].
In another study, microarrays were used to examine
kidney development in the rat [32]. Cluster analysis iden-
tified five groups of genes with interesting expression
patterns. The entire set of microarray data, for 8741
genes, has been made available (http://organogenesis.
ucsd.edu/). This work represents an important step in
the use of microarrays to perform a global analysis of
gene expression states in the developing kidney.
In this report,we extend these previous studies by per-
forming a microarray analysis of early kidney develop-
ment in the mouse. Affymetrix murine U74Av2 gene
chip probe arrays with over 12,000 genes represented
were used. Robust microamplification techniques were
used to allow study of extremely small samples. Gene
expression profiles were determined for microdissected
embryonic day E11.5 ureteric buds and metanephric
mesenchyme as well as E11.5, E12.5, E13.5, E16.5, and
adult total kidneys. The results identified extensive sets
of genes, of multiple functional categories, expressed in
developmental timing and compartment specific pat-
terns. In situ hybridizations were used to corroborate
microarray expression data and to further define the
expression patterns of selected genes during kidney de-
velopment. This work creates a catalogue of the gene
expression states of the total developing mouse kidney
and selected subcomponents. This provides a baseline
for the analysis of the many mouse mutants available
with altered kidney development.
METHODS
Dissection of early metanephric and adult tissues
and RNA isolation
E11.5 and E12.5 kidneys were dissected from wild-
type CD-1 mice, pooled, and frozen at 80C. Ureteric
buds and metanephric mesenchyme were microdissected
from E11.5 metanephric kidneys following mild trypsin-
ization, pooled separately, and then frozen at 80C.
E13.5, E16.5, and adult kidneys were isolated and frozen
at 80C. All dissections were performed in phosphate-
buffered saline (PBS).
Total RNA was prepared from ureteric bud, meta-
nephric mesenchyme, and early kidney samples using
Stratagene Absolutely RNA Nanoprep kit (La Jolla, CA,
USA) for small samples. Adult kidney and P1 whole
mouse total RNA was prepared using RNAzol (Tel-
Test, Friendwood, TX, USA).
RNA amplification and target RNA isolation
Total RNA was linearly amplified by using a pre-
viously described procedure [33] with 30 ng (ureteric
bud, metanephric mesenchyme, and two adult kidney
replicates) or 100 ng (remaining samples, including two
adult kidney replicates). Briefly, total RNA was reverse
transcribed into cDNA using a T7 promoter-dT primer
[5-GGCCAGTGAATTGTAATACGACTCACTATA
GGGAGGCGG-(T)24], amplified through an in vitro
transcription reaction using T7 RNA polymerase, and
the products then reverse transcribed into cDNA again,
using random hexamer primers. A final in vitro transcrip-
tion reaction using the Bioarray High Yield RNA tran-
script labeling kit (Enzo Life Sciences, Farmingdale, NY,
USA) was performed producing biotinylated cRNA for
microarray hybridization.
Microarray analysis of each developmental stage/tis-
sue of the developing kidney and adult kidney was per-
formed in biologic duplicate by obtaining tissues from
different mice. In addition, technical replicates of the
same adult kidney total RNA sample were performed
using both 30 ng and 100 ng amounts of total RNA.
Technical duplicates were also performed from the same
P1 whole mouse total RNA preparation. The same am-
plification procedure was used for all samples.
Gene expression profile analysis
Amplified, biotinylated cRNA samples were hybridized
to Affymetrix murine U74AV2 microarrays, according to
standard procedures as described by Affymetrix (Santa
Clara, CA, USA).
Both Microarrary Suite 5.0 (Affymetrix) and Gene-
Spring 4.2.1 and 5.1 (Silicon Genetics, Inc., Redwood
City, CA, USA) software were used for data analysis.
For cluster analysis, data were normalized using per chip
scaling in RMA [Affymetrix package in R that has been
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Fig. 1. Scattergram comparisons of microarray hybridizations. (A )
Technical replicate. Two 30 ng aliquots from a single adult kidney
RNA sample were processed in parallel and hybridized to two U74Av2
microarrays. The resulting scattergram shows less than 1% of genes
with more than a twofold difference in hybridization signal. (B ) Biologic
replicate. RNA samples from two separately dissected E12.5 kidneys
were processed in parallel. The resulting scattergram shows more varia-
tion than for the technical replicate, but again with well below 1% of
genes giving over a twofold difference in hybridization signal. (C )
Comparison of E12.5 and adult kidney microarray hybridization pat-
terns. A high level of biologic variation is observed. (D ) Comparison
of E11.5 ureteric bud and metanephric mesenchyme. Scattergrams show
comparisons of hybridization signals. Only genes with sufficient signal
to be called present by MAS5 for at least one of the two samples
being compared are shown. The scattergrams show comparisons of raw
hybridization signals of each probe set. For (A), for example, this results
in 101 probe sets called over twofold different in expression level on
the two microarrays. The MAS5 comparison, however, performs a more
sophisticated analysis of the probe set hybridization data and identified
only 43 genes with over a twofold difference. For both methods twofold
outliers are below 1% of total.
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
Fig. 2. Hierarchical cluster analysis of genes expressed in the early developing and adult kidney. (A ) Cluster analysis used several analysis of
variance (ANOVA)-based statistical criteria, which identified genes strongly expressed in developing or adult kidney. Genes with similar expression
profiles were clustered using hierarchical tree algorithm applied to the log relative gene expression values using Pearson correlation. Rows represent
the different tissues examined. Abbreviations are: MM, metanephric mesenchyme; UB, ureteric bud; W, whole mouse; all others, total kidney.
Red represents high expression, blue represents low expression, and yellow is intermediate, normalized to P1 whole mouse. A more complete set
of comparisons is available at http://genet.chmcc.org (login is Nephrome, password is reviewer, click login, not login as guest, click continue on
U74Av2_mouse).
developed by the Bioconductor Consortium (http://bio-
conductor.org)] followed by transformation of log2 sig-
nal back to linear signal that was then normalized to
the day 1 whole mouse reference. All group to group
comparisons (metanephric mesenchyme:ureteric bud,
E11.5:E12.5, E11.5:E13.5, E11.5:E16.5, E12.5:E13.5,
E12.5:E16.5, E13.5:E16.5, and adult kidney:whole mouse
for genes with relative expression more than twofold higher
in adult kidney) were performed using Welch t test analysis
of variance (ANOVA) with P  0.05 without multiple
testing rate correction because most samples were col-
lected and analyzed with two replicates. Genes that
passed the ANOVA were then ranked by average fold
difference with cutoffs used that were appropriate for
each comparison (twofold for each group), pooled,
and converted back to log expression ratios, which were
then subjected to the hierarchical tree clustering algo-
rithm with the Pearson distance metric as implemented
in GeneSpring 5.1 (Silicon Genetics, Inc.). All Affyme-
trix.cel files, RMA results, gene lists, and gene trees are
available at the following website: http://genet.chmcc.org
(login is Nephrome, password is reviewer, click login,
not login as guest, click continue on U74Av2_mouse).
RNA tissue section in situ hybridization
E12.5, E13.5, E15.5, and E17.5 embryos were obtained
from CD-1 mice. Embryos and tissues underwent fixa-
tion and embedding as previously described [15]. Four
micron sections, including the developing kidney, were
made. In situ hybridizations to RNA in tissue sections
were performed using a33P-uridine triphosphate (UTP)-
labeled riboprobe generated from cDNA clones. The fol-
lowing probes were made from the corresponding cDNA
clone: Birc5, 373242; Capn5, 733856; Cdrap, 427314;
Col15a1, 406344; Mns1, 480118; Nr2f1, 420535; Rab6kifl,
764732; Smoh, 439010; and Tgfbi, 734101. All cDNA
clones were obtained from the Incyte GEM1 mouse li-
brary (University of Cincinnati Genomics and Micro-
array Laboratory). Slides were then dipped in Kodak
NTB-2 nuclear track emulsion and exposed for 4 weeks
at 4C. After exposure, slides were developed using Ko-
dak D-19 developer at 15C. Slides were stained with
4,6-diamidino-2-phenylindole hydrochloride (DAPI).
RESULTS
The goal of this work was to establish a reference data
set of gene expression states during normal early mouse
kidney development. This data set could facilitate the
identification of new genes and pathways involved in
kidney development and provide a standard for micro-
array studies of the many mouse mutants available with
abnormal kidney development.
Reproducibility of the target amplification procedure
Powerful amplification techniques were necessary to
analyze the small samples provided by the early embry-
onic mouse kidneys and their microdissected compo-
nents. Several protocols were tried and the one described
by Baugh et al [33], using two rounds of in vitro transcrip-
tion, gave excellent results. Technical replicates were
performed to measure reproducibility of the resulting
microarray data. Total RNA was prepared from a single
adult kidney and multiple small aliquots were removed
and used in parallel for target amplification and hybrid-
ization to Affymetrix murine U74Av2 microarrays. Fig-
ure 1A shows a scattergram comparing the raw hybrid-
ization signals from two samples of 30 ng of total RNA.
Each point represents a single gene, with the hybridiza-
tion levels from the two microarrays shown on the two
axes. A single line at 45 would designate perfect repro-
ducibility. The two lines flanking the center line indicate
points of twofold difference in signal intensity in the two
microarray hybridizations. Figure 1A only shows genes
with sufficient hybridization signal to be called expressed
(P) by Microarray Suite 5.0 (MAS5). We observed a
high level of technical reproducibility for these genes
with well below 1% (43/12488) called more than a two-
fold different in expression by MAS5. Genes with very
low levels of expression, near noise, and called absent
or not-expressed by MAS5, gave more variation, but in
performing analyses, we used expression level cutoffs to
exclude these genes.
Biologic duplicates
In this study all kidney samples, embryonic and adult,
were examined in biologic duplicate, using RNA from
separate biologic samples. Figure 1B illustrates the re-
producibility of biologic duplicates for E12.5 kidneys. In
this case, the biologic noise was added to the technical
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noise, and as expected, more variation was observed
than for technical replicates. Nevertheless, in biologic
replicates, there were still well below 1% of genes show-
ing more than a twofold difference in gene expression.
This modest noise, of less than 1%, is almost entirely
eliminated by performing experiments in biologic dupli-
cate. The 1% of the approximately 12,000 genes on a
microarray is 120 genes, a significant number. But the
noise is largely random, so only 1% of these 120 genes,
or approximately one gene, would again show noise-
related variation on the duplicate.
The use of biologic duplicates provides a minimum of
two times two, or four, comparisons between two sample
types. By screening out genes with low expression levels
and genes with less than threefold change in expression,
we have previously observed over 95% of genes identi-
fied as differently expressed in such comparisons are vali-
dated by Northern blot, reverse transcription-polymerase
chain reaction (RT-PCR), and/or Western blot [31].
Gene expression state of the E12.5 kidney
The set of genes expressed in the embryonic kidney
defines its potential for growth and development. Mi-
croarrays, by providing a more comprehensive and unbi-
ased view, can promote the discovery of new genes not
previously implicated in developmental processes. For
example, 5542 genes were called expressed in both bio-
logic duplicates of the E12.5 kidney by MAS5, with the
detection P value set at the default 0.04. Errors in ab-
sence-presence calls occur most often for genes ex-
pressed at a low level, near noise. Excluding genes with
expression signal below 100 [glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) signal, for example, was 5237
and 5149 for the replicates], MAS5 called 3914 genes
expressed. Further screening of these genes by selection
with a detection P value of less than or equal to 0.03
found 3847 genes expressed in the E12.5 developing kid-
ney. This list of genes active during early kidney develop-
ment provides an important foundation for further study
of kidney morphogenesis. This gene collection is too
extensive for detailed discussion, but the data set is fully
provided at a supplementary Web site. All Affymetrix.
cel files, RMA results, gene lists, and gene trees are
available at http://genet.chmcc.org (login is Nephrome,
password is reviewer, click login, not login as guest, click
continue on U74Av2_mouse).
Genes with elevated expression levels
in the E12.5 kidney
Among the genes expressed in the developing kidney
are housekeeping genes and others of relatively little
developmental consequence, many of which will be ex-
pressed in both the embryonic and adult kidney. Of
particular interest from a development perspective are
the genes comparatively more active in the early devel-
oping kidney, which might play important roles in the
many processes of kidney formation. A scattergram pre-
sentation of the many differences in the gene expression
patterns of the E12.5 and adult kidneys is shown in Figure
1C. We performed a stringent screen of the microarray
data to identify genes with elevated expression levels in
the E12.5 embryonic kidney when compared to adult.
The E12.5 microarray analysis was performed in biologic
duplicate, and the adult kidney analysis was performed in
biologic duplicate, with one sample analyzed in technical
quadruplicate, giving a total of five adult microarrays,
and allowing a total of ten crosswise comparisons, be-
tween the two embryonic and five adult microarray hy-
bridizations. The microarray analysis software MAS5
found 1858 genes with consistently increased expression
levels in the embryonic kidneys versus adult in all ten
comparisons. Further screening of these genes required
that all ten comparisons show greater than threefold
(signal log ratio of 1.7) higher expression in embryonic
kidney, and that the expression signal in embryonic kid-
ney be greater than 150, to further reduce possible arti-
facts due to low signal to noise ratio.
This rigorous screen identified 428 genes with signifi-
cantly elevated expression in the embryonic kidney. Ap-
proximately 10% of these genes are involved in the regu-
lation of transcription (Table 1). Some of these (Taf1a,
Gtf2e2, Gtf2h1, and Taf9) can be grouped as general
transcription factors. Others play an important role in
regulating gene expression through their effects on chro-
matin configuration. These include the histone deacety-
lases genes Hdac1 and Hdac2, the SWI/SNF-related
Smarce1, BRG/brm-associated factor 53A, the HMG box
genes Hmgb2 and Hmga2, the chromobox homolog
Cbx2, the histone methylase gene silencer Setdb1, and
the Polycomb group genes eed and EZH2, which form a
complex together [34], and inactivate Hox genes through
histone methylation [35].
Another group of genes were found that likely encode
transcription factors based on motif, protein interactions,
or strong homologies to known transcription factors.
These include the zinc finger encoding genes Zfp105 and
Zfp61, the zinc finger homeobox gene Zfhx1a, the HMG
gene Hmgn2, and others such as Trp53bp1, Cbfb8,
Mcmd4, Cnbp6, and Trim27.
The E12.5 kidney also expressed 19 better-character-
ized transcription factor genes at elevated levels. Several
of these have been previously implicated in kidney devel-
opment. The only Hox genes identified by these strict
screening criteria were Hoxa 11 and Hoxd 11, which give
absent or rudimentary kidneys when both are mutated
[14, 15]. Pbx3, encoding a homeodomain protein that
interacts with Hox proteins was also identified. Sox11
was previously associated with mesenchyme-epithelia
transformation in kidney development by a differential
display study [36]. The Six2 gene was previously shown
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to be down-regulated in compound Hoxa 11, Hoxd 11,
Hoxc 11 triple mutant kidneys [16]. The Six, Eya, and
Dach genes form a regulatory network in several devel-
oping systems, and EYA1 mutant mice have absent kid-
neys [17]. Tcf12 encodes a basic helix loop helix tran-
scription factor. The forkhead FOXd1 (BF-2) gene, with
important function in stromal cells [23], was expressed.
The FOXc2 gene, also encoding a forkhead transcription
factor, was also expressed at elevated levels at E12.5.
FOXc2 has been implicated in the repression of GDNF
signaling, with FOXc1 mutants showing urinary tract
duplications and the FOXc1 and FOXc2 genes showing
considerable functional redundancy in both cardiovascu-
lar and kidney development [37]. N-Myc was also identi-
fied, and mutation of N-Myc gives poorly developed
kidneys [29]. The mesenchyme homeobox gene Meox2
is of interest. The Meox genes, also called Mox, have
been shown to interact with PAX proteins [38], which
are known to play a major role in kidney development.
In addition, the Meox genes have been implicated in
mesenchyme-epithelia interactions [39], again important
in kidney formation. Other transcription factor genes
identified include Zipro, a zinc finger proliferation gene,
Pttg1, a pituitary tumor transforming gene, Maged1, Tea
Domain gene TEAD2, the zinc finger Snail2, the inter-
leukin binding factor Ilf3, the MORF-related Mrgx, and
ERH (enhancer of rudimentary homolog).
It is clear from the microarray data that a major func-
tion of the early kidney is simply to grow. Thirty five
cell cycle–associated genes were found elevated in ex-
pression in the E12.5 kidney, consistent with a high rate
of cell division. An additional 90 genes with high expres-
sion in the developing kidney were involved in interme-
diary metabolism, ribosome biogenesis, DNA synthesis,
and other processes connected with rapidly dividing cells.
A similar conclusion was drawn in a previous microarray
study of rat kidney development [32].
Twenty one genes with roles in signaling were ex-
pressed at elevated levels in the mouse embryonic kid-
ney. Several of these are involved in guanosine triphos-
phatase (GTPase)-mediated signaling, including RAN
binding protein 1 (Ranbp1), Rac GTPase activating pro-
tein Racgap1, the oncogene ect2, and the ras homologs
Arhu and Ras-like family 2 locus 9 (Rasl2-9). Other genes
of interest were 2310076D10, involved in mitogen-acti-
vated protein kinase (MAPK) inactivation, and the Wsb1
gene, with a SOCS (suppressor of cytokine signaling) box.
Growth factor–related genes detected by this stringent
screen in the early kidney included GDNF, midkine,
secreted frizzled-related protein 2 (Sfrp2), follistatin-like
protein (FSTL), and hepatoma-derived growth factor–
related protein2 (Hdgfrp2). Although kidney develop-
ment functions for GDNF and midkine have been exten-
sively investigated [2, 6], the possible roles of Sfrp2,
Hdgfrp2 and follistatin-like protein in kidney formation
are largely unexplored.
Several interesting extracellular matrix (ECM)–
encoding genes were expressed at elevated levels in the
developing kidney. Chondroitin sulfate proteoglycan 6
(also called Bamacan) has been previously associated
with mesangial cells and tubulogenesis. Fibulin 1 and
laminin alpha 4 were also expressed, as was collagen
type V alpha 2. Glypican 3 mutations have been linked to
kidney malformations in both mice and humans [40, 41],
likely due to altered growth factor signaling [42]. Other
ECM genes of interest include microfibrillar-associated
protein 2 and Emu2. The Emu2 gene is often expressed in
mesenchymal cells undergoing mesenchymal-epithelial
interactions [43].
Many other genes of interest were found expressed at
elevated levels in the early embryonic kidney. These
included the protease inhibitors Serpinf1 and Serpinh1.
In addition, six receptor encoding genes were found, includ-
ing the nuclear receptor Nr2f1 (COUP-TF1), the ephrin
receptor Ephb4, the frizzled receptor Fzd2, the laminin
receptor 1, the netrin receptor Unc5h3, and the cytokine
receptor-like factor Crlf1. Several of these receptors can
be linked to known processes in kidney development.
For example, it is known that the ureteric bud cell line up-
regulates the expression of the membrane-bound ephrins
when undergoing branching morphogenesis in culture
[44]. There were also 125 expressed sequence tags (ESTs)
of currently unknown function that showed high expres-
sion levels in the developing kidney.
It is important to emphasize that this list of 428 genes
does not represent a complete compilation of develop-
mentally important genes expressed in the early devel-
oping kidney. It excludes, for example, many Hox genes
expressed in both the developing and adult kidney. The
high stringency of the screen also eliminated some genes
of known importance in kidney development. Other genes
were not represented on the microarrays. This study
does, however, implicate a large number of interesting
new genes in the process of kidney formation.
Genes differentially expressed between the E11.5
metanephric mesenchyme and ureteric bud
Gene expression profiles were determined for isolated
ureteric bud and metanephric mesenchyme of the early
developing kidney. These two elements were separated
by microdissection from E11.5 kidneys following mild
trypsinization. The similarity of the gene expression pat-
terns of these two compartments that give rise to the
kidney is shown in Figure 1D. Using a parametric t test
(P  0.05) we identified only 78 genes that were repro-
ducibly differentially expressed between the E11.5 meta-
nephric mesenchyme and ureteric bud (Table 2). This
relatively short list of consistent differences indicates
that the gene expression states of the metanephric mes-
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Table 2. A partial list of enriched genes and corresponding fold change from comparison of E11.5 metanephric mesenchyme and ureteric bud
E11.5 ureteric bud E11.5 metanephric mesenchyme
Name Description Fold changea Name Description Fold changea
Cell adhesion and extracellular matrix Cell adhesion and extracellular matrix
Cdh Cadherin 16 16 None
Cldn3 Claudin 3 9.8, 18.4b
Cldn4 Claudin 4 16.3
Cldn7 Claudin 7 29.9
Cldn8 Claudin 8 4.5
Emb Embigin 4.7
Lamc2 Laminin, gamma 2 10.6
Ppl Periplakin 2.5
Cell cycle Cell cycle
Cdkn1a Cdk inhibitor 1a (p21) 2.8, 4.9b Cnn2 Calponin 2 3.5
Protein modifiers and enzymes Protein modifiers and enzymes
Capn5 Calpain 5 2.1 Alas2 Aminolevulinic acid synthase 2 3.6
Hpn Hepsin 3.4 Lyzs Lysozyme 5.6
Tmprss2 Transmembrane protease, ser 2 6.5
Signal transduction Signal transduction
Calb1 Calbindin-28k 19 Fes Feline sarcoma oncogene 2.6
Calcr Calcitonin receptor 28.3 Klra7 Killer cell lectin-like receptor, A7 2.1
Gfra1 Gdnf receptor alpha 1 3.2 Sgk Serum/glucocorticoid regulated kinase 3
Itk Il2-inducible t-cell kinase 3.3 Tek Endothelial receptor tyrosine kinase 3.1
Ros Ros1 proto-oncogene 11.9, 16.0b Tie1 Tyrosine kinase receptor 1 9.4
Tacstd2 Tumor-associated calcium signal transducer 2 11.9
Tgfa Tgf alpha 3.5
Tnfrsf19 Tnf receptor 19 4.2
Vsnl1 Visinin-like 1 5.5
Wnt6 Wnt 6 9
Transcription Transcription
En2 Engrailed 2 2.2 C1d Nuclear DNA binding protein 2.6
Pea3 Polyoma virus enhancer activator 3 2.9 Foxc1 Forkhead box C1 3.8
Tcf2 Transcription factor 2 16.3 Hoxa10 Homeo box A10 3
Sox2 SRY-box containing gene 2 2.8
Sox18 SRY-box containing gene 18 6.7
Wt1 Wilms tumor homolog 9
Transport Transport
None Hba-a1 Hemoglobin alpha, adult 1 4.1
Hbb-b1 Hemoglobin beta, adult 1 4.8
Vamp5 Vesicle-associated membrane protein 5 6.1
a Fold change denotes the average fold change. Signal log ratio (SLR) for each probe set was generated using comparison files from Affymetrix MAS 5.0 and
converted into fold change according to MAS 5.0 documentation.
b Genes represented by two probe sets and the corresponding fold change for each
enchyme and ureteric bud are surprisingly similar, per-
haps reflecting their common intermediate mesoderm
origin. We identified 53 genes with increased expression
in the ureteric bud, and 25 genes with increased expres-
sion in the metanephric mesenchyme.
Ureteric bud–enriched genes
The list of ureteric bud–enriched genes includes many
previously shown to be important in metanephric kidney
development, or specifically associated with epithelial
structures. Ten of the 53 genes more highly expressed
in the ureteric bud function in forming cell-cell adhesions
or ECM (Table 2). Claudin genes 3, 4, 7, and 8 were
enriched in the ureteric bud. Claudins are integral mem-
brane proteins that function in forming tight junctions
between epithelial cells. Cartilage-derived retinoic acid–
sensitive protein is an ECM protein containing a SH3
domain that is repressed in the presence of retinoic acid
and functions in cell culture as a tumor growth inhibitor
[45, 46]. Cadherin 16 was first identified as a kidney-
specific cadherin and is expressed in the epithelia of the
developing kidney [47, 48]. Laminin gamma 2 is a subunit
of the laminin-5 complex and is found within the basal
lamina of the ureteric bud [49]. In vitro studies have
shown that ureteric bud branching is decreased when
laminin-5 is blocked through use of antibodies to itself
and its receptors, the 3 and 6 integrins [50].
Genes with elevated expression in the bud also include
growth factors and signal transducers. Two identified
growth factors, TGF- and WNT6, were previously im-
plicated in kidney development. TGF- is expressed in
the ureteric bud tips and ducts and is able to induce meta-
nephric kidney growth in vitro, while growth is inhibited
by TGF- antibodies [51, 52]. WNT6 is expressed in ure-
teric bud and can induce nephrogenesis in vitro [5].
Notable signaling transducers detected in the ureteric
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bud include GFRA1, FGFr3, and ROS1. GFRA1 is co-
receptor for RET, which is also expressed in the ureteric
bud. Mutation of Gfra1 gives a similar phenotype to the
GDNF and Ret knockout mice, in which there is an
absent kidney due to loss of ureteric bud outgrowth [53].
FGFr3, a fibroblast growth factor (FGF) receptor, may
function in early signaling within the metanephric kid-
ney, as expression of a secreted dominant-negative FGF
receptor in transgenic mice results in kidney agenesis [54].
Several genes involved in calcium-mediated signaling
showed elevated expression in the ureteric bud. This is
consistent with the observed response of Madin-Darby
canine kidney (MDCK) cells, which quickly become
polarized and form tight junctions and desmosomes fol-
lowing calcium level elevation [55]. VSN11 is a calcium-
dependent regulator of cellular signaling [56]. The calci-
tonin receptor is known to regulate Ca excretion in
the kidney and might also play a role in organogenesis
[57]. Calbindin-28K, a calcium-binding protein, was pre-
viously shown to be expressed in the ureteric bud [58],
and TACSTD2, a tumor-associated calcium signal trans-
ducer, also showed elevated expression the ureteric bud.
Only four ureteric bud elevated genes, including Tcf2,
Pea3, and En-2, encoded known transcription factors.
Tcf2 is expressed in the forming collecting ducts in the
developing kidney as well as in the liver [59]. Tissue-
specific targeting in the liver shows that this gene is
essential for bile duct morphogenesis [60], suggesting a
possible role in branching morphogenesis in the kidney.
Recently, Pea3 has been implicated in muscle innerva-
tion. Of interest, Pea3 is downstream of GDNF in motor
neurons [61]. En-2, an engrailed homolog, has been
found to regulate boundaries in the developing brain
and has not been previously implicated in kidney devel-
opment [62].
Other genes identified encoded proteases and protein
modifiers such as CAPN5, hepsin, and transmembrane
protease 2. Also, a cell cycle regulator, Cdkn1a, was
identified. Other genes with elevated expression in the
ureteric bud were involved in metabolism, the cytoskele-
ton, or of unknown function, including ESTs.
Metanephric mesenchyme–enriched genes
We identified 25 genes more highly expressed in the
metanephric mesenchyme than in the ureteric bud. Six
of these encoded the transcription factors WT-1, FOXc1,
SOX2, SOX18, HOXA 10, and C1D. The WT-1 gene
has previously been shown to be expressed in the meta-
nephric mesenchyme and is required for early kidney
development [18]. FOXc1, a forkhead/winged helix tran-
scription factor, as discussed previously, is an apparent
regulator of GDNF signaling. Sox2 and Sox18 encode
transcription factors containing HMG boxes. For Hoxa
10, we have confirmed restricted expression in the meta-
nephric mesenchyme (Patterson, unpublished observa-
tions, 2003). C1D is a DNA high-affinity binding protein
that serves as a nuclear receptor corepressor [63].
Genes encoding four signal transduction proteins,
TEK, TIE1, SGK, and FES, were enriched in the meta-
nephric mesenchyme. TEK and TIE1, receptor tyrosine
kinases, function in vascular endothelium development
and mutations in these genes cause endothelial defects
[64, 65]. Of particular interest, TIE-deficient cells were
unable to contribute to adult kidney epithelium in chime-
ras [65]. Sgk1 encodes a serum/glucocorticoid-regulated
kinase. Targeted mutation of sgk1 gives an impaired
sodium retention phenotype [66]. The protein kinase
FES has been reported expressed in epithelia cells, he-
matopoietic cells, and vascular endothelial cells [67].
Transgenic studies indicate a role for FES in angiogen-
esis [68]. Targeted mutation of the fes gene revealed
function in cardiovascular development and myeloid cell
proliferation [69]. It is interesting that the E11.5 mesen-
chyme already expressed so many genes (Sox18, tek, tie,
and fes) associated with vasculogenesis.
Other genes of interest more highly expressed in the
metanephric mesenchyme included Vamp5, which en-
codes an integral membrane protein that is enriched
during in vitro myogenesis and is highly expressed in
heart and skeletal muscle, but with lower levels also
detected in the adult kidney and other organs by North-
ern blot [70]. Adult hemoglobin alpha and beta chains,
lysozyme (Lyzs), an antimicrobial enzyme produced by
macrophages, and aminolevulinic acid synthase 2 (Alas2),
an erythroid-specific enzyme functioning in heme pro-
duction, are enriched within the metanephric mesen-
chyme. The elevated expression of these blood-related
genes could simply reflect a greater blood content for
the metanephric mesenchyme compared to the ureteric
bud. Alternatively, it could suggest a possible hemato-
poietic function for the metanephros, similar to that pre-
viously described for the mesonephros. Five EST genes,
with unknown functions, were also enriched in the meta-
nephric mesenchyme.
Genes with elevated expression at E16.5
The E16.5 kidney showed elevated expression of many
genes when compared to E12.5 (Table 3). Of particular
note, there were 32 aquaporin, ion channel, solute car-
rier, and other transport molecules actively expressed
at E16.5, consistent with ongoing tubule maturation. A
number of other genes with previously assigned kidney
function were also identified, including nephronectin (in-
tegrin ligand), polyductin (polycystic kidney disease),
neuropilin (semaphorin receptor), uromodulin, glomer-
ular epithelial protein 1, and renin. In addition, a large
number of genes not previously associated with kidney
development, from a variety of functional categories,
were found (Table 3).
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Table 3. Elevated expression in the E16.5 embryonic kidney, compared to E12.5
Name Description Fold changea Name Description Fold changea
Cell adhesion and ECM
Alcam Activated leukocyte cell adhesion molecule 5.8 Gpc4 Glypican 4 5.8
Cdh16 Cadherin 16 4.3 Igsf4 Immunoglobulin superfamily, 4 8.6
Cldn1 Claudin 1 7.7 Itga6 Integrin alpha 6 5.0
Cldn11 Claudin 11 5.5 Muc1 Mucin 1 17.4
Dcn Decorin 8.0 Spp1 Secreted phosphoprotein 1 13.5
Dutt1 Roundabout homolog 1 4.7 Timp3 Tissue inhibitor of metalloproteinase 3 4.1
Cytoskeletal
Acta2 Actin, alpha 2 6.3 Myo6 Myosin VI 4.6
Ank3 Ankyrin 3 4.8 Scin Scinderin 42.2
Enah Enabled homolog 26.9 Sorbs1 Sorbin and SH3 domain 1 4.4
Kif5b Kinesin family, 5B 7.0 Sprr2f Small proline-rich protein 2F 20.7
Myh11 Myosin heavy chain 11 6.6 Vil Villin 66.3
Growth factor
Cish2 Cytokine inducible SH2-containing 2 8.0 Kng Kininogen 5.3
Ctgf Connective tissue growth factor 4.2 Nrp Neuropilin 7.5
Dab2 Disabled homolog 2 7.9 Ogn Osteoglycin 10.7
Emp1 Epithelial membrane protein 1 4.4 Penk1 Spermatogenic-specific proenkephalin 16.0
Eps8 EGFR pathway substrate 8 10.9 Pkhd1 Polyductin 38.1
Fin15 FGF inducible 15 20.7 POEM POEM; nephronectin 5.1
Gadd45 GADD45 protein 25.5 Pparbp Ppar binding protein 10.9
Htk Ephrin B2 4.4 Sdfr2 Stromal cell derived factor receptor 2 11.9
Igf1r Insulin-like growth factor I receptor 5.3 Sfrp1 Secreted frizzled-related 1 6.3
Igfbp7 Insulin-like growth factor binding protein 7 8.1 Umod Uromodulin 26.0
Kinases and phosphatases
Csnk1e Casein kinase 1, epsilon 3.9 Pdpk1 3-PI dependent protein kinase 1 4.1
Emk ELKL motif kinase 8.1 Ppp1cb Protein phosphatase 1, beta 5.7
Glepp1 Glomerular epithelial protein 1 precursor 29.9 Snrk SNF related kinase 6.4
Hipk2 Homeodomain interacting protein kinase 2 6.0 Mylk Myosin, light polypeptide kinase 7.5
Mekk1 MAP kinase kinase kinase 1 10.4
Protease and protease inhibitors
Cast Calpastatin 8.0 Serpinf2 Ser or Cys proteinase inhibitor, F2 5.5
Cfi Complement factor i 28.8 Mep1b Meprin 1 beta 105.8
Ctsh Cathepsin H 6.3 Kdap Kidney-derived Asp protease-like 7.2
Signaling
ACE2 Angiotensin-converting related carboxypeptidase 3.8 Ndrl N-myc downstream regulated-like 5.2
Admr Adrenomedullin receptor 4.6 Pdzk1 PDZ domain containing 1 137.2
Apbb2 A4 precursor protein-binding, B2 4.4 Pkib Protein kinase inhibitor beta 6.1
Calb3 Calbindin-D9K 19.0 Procr Protein C receptor, endothelial 6.0
Calml4 Calmodulin-like 4 10.4 Rasd1 RAS, dexamethasone-induced 1 4.6
Cckar Cholecystokinin type-A receptor 13.5 Ren1 Renin 1 structural 19.4
Dab2 Disabled homolog 2 6.5 RhoB Ras homolog gene, AB 4.4
Ednrb Endothelin receptor type B 84.4 Semcap2 SemaF cytoplasmic associated protein 2 14.9
Gna11 G nucleotide binding protein, alpha 11 10.7 Styx Phospho Ser/Thr/Tyr interaction protein 73.5
Gna13 G nucleotide binding protein, alpha 13 78.8 Tia1 Cytotoxic granule-associated protein 1 4.6
Gnai1 G nucleotide binding protein, alpha inhibiting 1 4.8 Ube3a Ubiquitin protein ligase E3A 7.9
Hrsp12 Heat-responsive protein 12 4.4 Itgp Integrin-associated protein 10.9
Il13ra1 Interleukin 13 receptor, alpha 1 8.0
Transcription
Cbx1 Chromobox homolog 1 7.5 PABII Poly(A) binding protein II 43.7
Cited2 Cbp/p300-interacting transactivator 2 15.7 Nfib Nuclear factor I/B 4.3
Crtr1 Transcription repressor CRTR-1 4.4 Nfix Nuclear factor I/X 30.4
Ddx3 DEAD box 3 17.4 Nmi N-myc (and STAT) interactor 8.4
Ddx36 DEAD/H box 36 4.5 Nrip1 Nuclear receptor interacting protein 1 28.8
Ddx6 DEAD box 5 5.8 Pcaf p300/CBP-associated factor 6.7
Elf5 E74-like factor 5 5.1 Peg3 Zinc finger protein 6.6
Elk3 ETS oncogene member 8.3 Pou2f1 POU domain, 2-1 5.2
Etv1 Ets variant gene 1 4.2 Smarcc1 SWI/SNF related, regulator of chromatin, C1 6.2
Gata3 GATA binding protein 3 6.3 Sp1 Trans-acting transcription factor 1 18.1
Id4 Inhibitor of DNA binding 4 7.9 Tcf2 Transcription factor 2 4.0
Klf5 Kruppel-like factor 5 7.9 Terf2 Telomeric repeat binding factor 2 8.1
Mad4 Max dimerization protein 4 5.2 Zfp36l2 Zinc finger protein 36, C3H type-like 2 4.4
Mafg V-maf, G 4.8 KF-1 KF-1, Zinc finger protein 103 7.9
(Continued)
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Table 3. Continued
Name Description Fold changea Name Description Fold changea
Transport
Abcg2 ATP-binding cassette, G2 4.2 Kcnj1 Potassium channel, J1 23.0
Anxa11 Annexin A11 9.5 Lamp2 Lysosomal membrane glycoprotein 1 18.4
Aqp1 Aquaporin 1 13.2 Mal T-cell differentiation protein 6.6
Aqp2 Aquaporin 2 5.3 NKCC2 Kidney-specific Na-K-Cl cotransport B 81.6
Atp6v1a1 ATPase, H transporting, A1 8.3 Slc16a7 Solute carrier family 16, member 7 27.4
Atp7a ATPase, Cu transporting, A 4.7 Slc17a1 Solute carrier family 17, member 1 6.3
Tm9sf3 Transmembrane protein 9, member 3 4.0 Slc22a1 Solute carrier family 22, member 1 4.5
Cav3 Caveolin 3 8.9 Slc22a2 Solute carrier family 22, member 2 17.8
Clcn3 Chloride channel 3 24.3 Slc22a6 Solute carrier family 22, member 6 20.7
Clcn4-2 Chloride channel 4-2 4.1 Slc27a2 Solute carrier family 27, member 2 4.4
Cubn Cubilin 8.7 Slc2a2 Solute carrier family 2, member 2 10.6
Fabp3 Fatty acid binding protein 1 6.1 Slc34a1 Solute carrier family 34, member 1 7.1
Fmo1 Flavin-containing monooxygenase 1 6.5 Slc5a1 Solute carrier family 5, member 1 54.8
Folr1 Folate receptor 1 9.2 Snca Synuclein, alpha 4.4
Fxyd2 FXYD domain ion transport regulator 2 32.6 Stx3 Syntaxin 3A 6.1
Gsr Glutathione reductase 1 7.0 Itpr2 IP3 receptor type 2 39.4
a Fold change denotes the average fold change. Signal log ratio (SLR) for each probe set was generated using comparison files from Affymetrix MAS 5.0 and
converted into fold change according to MAS 5.0 documentation.
Cluster analysis of gene expression during
kidney development
A more comprehensive view of the changes in gene
expression that take place during kidney development
can be provided by hierarchical cluster analysis (Fig. 2).
Rows represent the different tissues examined, which
included E11.5 metanephric mesenchyme, E11.5 ureteric
bud, E11.5, E12.5, E13.5, E16.5, and adult total kidney,
as well as P1 total mouse. Genes with similar expression
patterns were clustered using hierarchical tree algorithm
applied to the log relative gene expression values using
Pearson correlation. Red represents high expression and
blue represents low expression levels. The genes on the
right showed higher expression in the adult kidney, and
genes on the left had higher expression in the developing
kidney. Figure 2 also provides graphic illustration of the
similarities in gene expression patterns of the embryonic
kidney at E11.5, E12.5, and E13.5. Compared with the
striking embryo-adult differences, the changes in gene
expression at these early developmental time points are
subtle. The E16.5 kidney, in contrast, shows a distinctive
gene expression profile when compared with either the
embryonic or adult kidney, consistent with its intermedi-
ate state of differentiation.
In situ hybridization confirmation of
microarray results
To confirm and extend the microarray results, we per-
formed in situ hybridizations. The microarray data iden-
tified a large number of interesting genes, many of which
had been previously implicated in kidney development,
providing significant validation of the approach. For
other genes there had been only indirect, or in many
cases no previous association with kidney formation. To
corroborate predictions of the microarray data and to
better define the expression patterns of selected genes
in the developing kidney, we performed in situ hybridiza-
tions.
The Smoothened (Smoh) gene was predicted by the
microarray results to be expressed in the early devel-
oping kidney. In situ hybridizations showed a graded
Smoh expression pattern in the E12.5 metanephric mes-
enchyme, with higher levels in prestromal regions more
distant from the ureteric bud (Fig. 3 A to C). This is
consistent with a recent study showing that SHH expres-
sion in the ureteric bud is an important regulator of
proliferation and differentiation of the metanephric mes-
enchyme in the developing kidney [71].
Nr2f1 (COUP-TFI) expression was observed in the
mesenchyme of the E13.5 kidney (Fig. 3 D to F). Similar
to Smoh, expression was excluded from the bud and
its flanking mesenchyme. At E15.5, Nr2f1 expression
remained off in the developing collecting ducts and was
maintained in mesenchyme and forming tubules (Fig.
3 G to I). Nr2f1 is an orphan member of the nuclear
receptor family with no identified ligand [72]. It was
previously shown to be highly expressed in developing
neural tissue of the brain [73] and when knocked out in
the mouse defects are observed in development of the
peripheral nervous system ganglia [74].
At E17.5, Birc5 (survivin) expression was observed in
the developing tubules and glomeruli (Fig. 3 J to L). This
gene functions to enhance proliferation and survival of
cells.
Capn5 expression was limited to the epithelia of the
collecting ducts at E15.5 (Fig. 3 M to O). This gene is a
member of the calpain family, which encodes calcium-
dependent intracellular proteases but lacks a calmodu-
lin-like domain [75] and may act within signaling cas-
cades [76].
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Fig. 3. In situ hybridization analysis of gene expression patterns in the
developing kidney. (A to C ) At E12.5, Smoh expression was found in
the metanephric mesenchyme with the highest expression localized to
the prestromal mesenchyme (arrows). Also, notice the absence of signal
within the branching ureteric bud (arrowhead). (D to F ) Nr2f1 expres-
sion was diffuse throughout the metanephric mesenchyme in the E13.5
developing kidney, while expression was not found within the branching
ureteric bud (arrowheads). (G to I ) Later in the developing kidney, at
E15.5, Nr2f1 expression was maintained in the mesenchyme, and was
found in the smaller tubular structures (arrows), but was absent in the
mature ureteric stalks (arrowheads). (J to L ) The Birc5 gene was highly
expressed in the tubular structures of the E17.5 kidney (arrowheads)
and in developing glomeruli (arrows). (M to O ) Capn5 expression in
the E15.5 kidney. High expression was restricted to epithelia of the
large diameter ureteric stalks (arrows), while decreased expression is
identified in the smaller ureteric tips (arrowheads) located at the periph-
ery of the developing kidney. (P to R ) Mns1 expression in the E15.5
kidney was mainly localized to the early nephrogenic epithelia (arrows)
within the cortex of the developing kidney and an S-shaped body (arrow-
head). (S to U ) Rab6kifl expression in the developing urogenital system
at E12.5 was localized to mesenchyme surrounding the ureter (arrow)
while absent from the mesenchyme surrounding the ureteric bud (ar-
rowheads). (M to O) taken at 100	; all other images taken at 200	.
Serial sagittal sections. (A, D, G, J, M, P, and S) show DAPI fluores-
cence. Dark-field imaging was used to view the hybridization signal (B,
E, H, K, N, Q, and T). (C, F, I, L, O, R, and U) show overlays of dark-
field image over the DAPI fluorescent image.
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Fig. 4. Similar expression patterns within the developing lung and kidney suggesting roles in branching morphogenesis. (A to C ) Cdrap showed
high expression in the E17.5 kidney localized to the distal ends of the ureteric bud (arrowheads) at the periphery of the kidney. (D to F ) A similar
expression pattern for Cdrap was seen in the E15.5 lung with expression localized at the distal tips of the branching distal bronchi (arrows), while
the proximal bronchi (arrowhead) lack Cdrap expression. (G to I ) Tgfbi expression in the metanephric mesenchyme at E12.5 was diffuse with no
detectable signal in the ureteric bud (arrowheads). There was high Tgfbi expression in the mesenchyme surrounding the Wolffian (mesonephric)
duct (arrow). (J to L ) The mesenchymal-specific expression pattern of Tgfbi was maintained in the E15.5 kidney within the nephrogenic mesenchyme
surrounding the ureteric-derived duct (arrowheads), but decreased or absent expression was identified in mesenchymal-derived structures, including
an S-shaped body (arrow) and immature glomeruli (asterisks). (M to O ) A similar expression pattern was found in the lung at E15.5, with signal
localized to the mesenchyme surrounding the bronchi (arrows). (P to R ) Early in kidney development, at E13.5, Col15a1 was highly expressed
within patches of mesenchyme surrounding the ureteric epithelia (arrowheads). (S to U ) Later, in the E15.5 metanephric kidney, Col15a1 was
highly expressed within the mesenchyme surrounding the ureteric bud–derived ducts (arrows), but absent in S-shaped bodies (arrowheads). (V to
X ) A similar expression pattern for Col15a1 was found in the E13.5 lung, with high signal in patches of mesenchyme surrounding the bronchi
(arrows). (Y to A’) Later in development, the E15.5 lung showed a diffuse mesenchymal Col15a1 expression pattern surrounding the proximal
bronchi (arrows) and distal branching bronchi (arrowhead). Sections were stained with DAPI (A, D, G, J, M, P, S, V, and Y). Dark-field imaging
was used to view the signal (B, E, H, K, N, Q, T, W, and Z). (C, F, I, L, O, R, U, X, and A’) show overlays of dark-field image over the fluorescent
image. All images were taken at 200	.
The Mns1 gene (meiosis-specific nuclear structural
protein 1) [77] showed expression in the early nephro-
genic epithelia in the cortex (Fig. 3 P to R). The Rab6kifl
gene showed restricted expression in the mesenchyme
surrounding the ureter in the E12.5 kidney (Fig. 3 S to U).
The Rab6kifl encoded protein is localized to the golgi
apparatus and includes a kinesin motor domain as well
as a Rab6 GTP interacting domain [78].
Although the focus of this study is on the developing
kidney, the in situ hybridizations also defined expression
domains in the other regions of the embryo. For some
genes the expression patterns in the developing lung,
which also undergoes extensive branching morphogene-
sis, were particularly striking.
The Cdrap (or MIA) gene was originally cloned as a
secreted protein from human melanoma cell lines. It was
reported expressed in cartilage primordia [46], as well
as transiently in embryonic mammary buds, suggesting
a possible role in embryonic events involving invasive
growth [79]. Cdrap is a secreted ECM protein that adopts
an SH3 domain-like fold in solution. The gene was re-
cently knocked out. Malformations were detected in
mutant mice in collagen fiber density, diameter and ar-
rangement [80]. The mice are viable and have normal
mammary gland development, but other tissues were not
extensively examined. The microarray results suggested
that Cdrap is expressed in the ureteric bud of the devel-
oping kidney. As predicted, Cdrap showed high expres-
sion in the distal ends of the branching ureteric bud of
the E17.5 embryo (Fig. 4 A to C). Of interest, we also
observed Cdrap expression in the distal tips of the
branching bronchi of the lung (Fig. 4 D to F).
The Tgfbi gene was isolated as a gene that is induced
by TGF-1, and prevents cell adhesion [81]. It is mutated
in corneal dystrophies [82]. The protein is a secreted,
RGD-containing collagen-associated protein, and is
thought to interact with the ECM. Consistent with the
microarray results, this gene was expressed in the mesen-
chyme of the developing kidney at both E12.5 and E15.5
(Fig. 4 G to L). Similar expression was found in the
developing lung at E15.5 (Fig. 4 M to O). These results
support and expand earlier expression analysis of this
gene [83].
There is evidence from cell culture studies that the
collagen Col15a1 gene may be modulated by cytokines
[84]. The gene has been previously targeted causing mus-
cular disease and defects detected in the cardiovascular
system in mice [85]. In situ hybridizations confirmed
the microarray predicted expression in the developing
kidney, with distinct patches of expression observed in
the mesenchyme of both the kidney and lung at E13.5
and E15.5 (Fig. 4 P to A’). This data support and expand
a previous Col15a1 expression analysis [86].
DISCUSSION
By coupling microarrays and robust target amplifica-
tion techniques it is possible to perform global studies
of the gene expression patterns of early developing or-
gans and microdissected subcomponents. In this report,
we present a catalogue of the gene expression states of
the early developing mouse total kidney as well as the
separated ureteric bud and metanephric mesenchyme
compartments.
The 20 Affymetrix U74A microarrays used for this
study generated over 240,000 gene expression level data
points, which were analyzed by multiple crosswise com-
parisons as well as hierarchical cluster analysis. Hun-
dreds of genes expressed at much higher levels in the
developing kidney than the adult were found, while far
fewer differences in gene expression patterns were found
between the multiple early embryonic kidney samples.
A surprisingly high fraction of the known genes to
emerge from this study had been formerly implicated in
kidney development or processes related to branching
morphogenesis. This serves to authenticate the screen.
In some cases, however, previously characterized genes
had not been reported expressed in the developing kid-
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ney. For selected genes, we performed in situ hybridiza-
tions to more precisely define spatiotemporal expression
patterns.
The in situ hybridization results confirmed the mi-
croarray-predicted kidney development expression. In-
teresting similarities in expression patterns in the kidney
and lung, which both undergo branching morphogenesis,
were also observed for three genes, Cdrap, Tgfbi, and
Col15a1. It is interesting to note, however, that for some
of these genes, targeted mutant mice have been made
and no kidney phenotype observed. This could reflect
expression without kidney development function, func-
tional redundancy, or the presence of a previously unde-
tected kidney phenotype in the mutant mice. Even se-
verely malformed kidneys can often provide sufficient
function for survival. It would be interesting to begin to
distinguish these possibilities by reexamination of these
mutants.
Not all of the expected genes are actually identified
in the comparisons. For example, over 30 Hox genes are
expressed in the developing kidney, but most do not
appear on the list of transcription factors expressed at
elevated levels during development. There are several
possible reasons for these absences. Some genes are sim-
ply not on the U74Av2 microarrays. Other genes are
expressed at low, near noise, levels and are deliberately
excluded to avoid artifacts. Additional genes are ex-
pressed at similar levels in both samples being compared,
and are therefore not called different. Furthermore, the
high stringency of the screening process eliminated some
genes.
This work provides an extensive definition of gene
expression states during mouse kidney development.
The results suggest kidney development function for a
large number of genes not previously implicated in this
process. The complete data set is available (http://genet.
chmcc.org Login, Nephrome with password “reviewer”).
Since this work was performed with the standard com-
mercial Affymetrix microarray platform, the resulting
gene expression profiles can provide baselines for multi-
ple future studies of kidney development in mouse mu-
tants.
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